Tags

Type your tag names separated by a space and hit enter

[Transurethral seminal vesiculoscopy for refractory or recurrent hemospermia: clinical analysis of 162 cases].
Zhonghua Nan Ke Xue. 2013 Jun; 19(6):531-4.ZN

Abstract

OBJECTIVE

To investigate the feasibility and effect of transurethral seminal vesiculoscopy in the diagnosis and treatment of refractory or recurrent hemospermia.

METHODS

We retrospectively analyzed 162 cases of refractory or recurrent hemospermia examined and treated by transurethral seminal vesiculoscopy. The patients ranged in age from 19 to 76 years and had a hemospermia history of 3 months to 11 years, admitted due to poor therapeutic results or recurrence after 4 weeks of antibiotic medication. All the patients underwent serum PSA examination, transrectal ultrasonography, seminal vesicle ultrasonography and pelvis CT or MRI before surgery.

RESULTS

Wine- or magenta-colored colloid and inflammation were found in one or both sides of the seminal vesicle in all the cases. Pathological biopsy revealed chronic inflammatory mucosa of the seminal vesicle in all the patients, and even calculi in the ejaculatory duct or seminal vesicle in 15 cases. Postoperative follow-up averaged 21.7 (12 -29) months. Hemospermia disappeared or was alleviated in 150 (92.64%) of the cases after 1-15 ejaculations, in which 7 experienced recurrence 3 months later. Four cases failed to respond, and 1 developed acute bilateral epididymitis after surgery. No such complications as retrograde ejaculation, urinary incontinence or rectal injury were observed postoperatively.

CONCLUSION

Transurethral seminal vesiculoscopy is a safe, effective and feasible new method for the treatment of refractory or recrudescent hemospermia.

Authors+Show Affiliations

Department of Urology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

chi

PubMed ID

23862232

Citation

Wang, Lei, et al. "[Transurethral Seminal Vesiculoscopy for Refractory or Recurrent Hemospermia: Clinical Analysis of 162 Cases]." Zhonghua Nan Ke Xue = National Journal of Andrology, vol. 19, no. 6, 2013, pp. 531-4.
Wang L, Liu ZY, Xu CL, et al. [Transurethral seminal vesiculoscopy for refractory or recurrent hemospermia: clinical analysis of 162 cases]. Zhonghua Nan Ke Xue. 2013;19(6):531-4.
Wang, L., Liu, Z. Y., Xu, C. L., Sun, Y. H., Wan, P., Sheng, X., Xiao, L., Piao, S. G., Ye, H. M., & Lu, X. (2013). [Transurethral seminal vesiculoscopy for refractory or recurrent hemospermia: clinical analysis of 162 cases]. Zhonghua Nan Ke Xue = National Journal of Andrology, 19(6), 531-4.
Wang L, et al. [Transurethral Seminal Vesiculoscopy for Refractory or Recurrent Hemospermia: Clinical Analysis of 162 Cases]. Zhonghua Nan Ke Xue. 2013;19(6):531-4. PubMed PMID: 23862232.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Transurethral seminal vesiculoscopy for refractory or recurrent hemospermia: clinical analysis of 162 cases]. AU - Wang,Lei, AU - Liu,Zhi-Yong, AU - Xu,Chuan-Liang, AU - Sun,Ying-Hao, AU - Wan,Peng, AU - Sheng,Xia, AU - Xiao,Liang, AU - Piao,Shu-Guang, AU - Ye,Hua-Mao, AU - Lu,Xin, PY - 2013/7/19/entrez PY - 2013/7/19/pubmed PY - 2014/5/16/medline SP - 531 EP - 4 JF - Zhonghua nan ke xue = National journal of andrology JO - Zhonghua Nan Ke Xue VL - 19 IS - 6 N2 - OBJECTIVE: To investigate the feasibility and effect of transurethral seminal vesiculoscopy in the diagnosis and treatment of refractory or recurrent hemospermia. METHODS: We retrospectively analyzed 162 cases of refractory or recurrent hemospermia examined and treated by transurethral seminal vesiculoscopy. The patients ranged in age from 19 to 76 years and had a hemospermia history of 3 months to 11 years, admitted due to poor therapeutic results or recurrence after 4 weeks of antibiotic medication. All the patients underwent serum PSA examination, transrectal ultrasonography, seminal vesicle ultrasonography and pelvis CT or MRI before surgery. RESULTS: Wine- or magenta-colored colloid and inflammation were found in one or both sides of the seminal vesicle in all the cases. Pathological biopsy revealed chronic inflammatory mucosa of the seminal vesicle in all the patients, and even calculi in the ejaculatory duct or seminal vesicle in 15 cases. Postoperative follow-up averaged 21.7 (12 -29) months. Hemospermia disappeared or was alleviated in 150 (92.64%) of the cases after 1-15 ejaculations, in which 7 experienced recurrence 3 months later. Four cases failed to respond, and 1 developed acute bilateral epididymitis after surgery. No such complications as retrograde ejaculation, urinary incontinence or rectal injury were observed postoperatively. CONCLUSION: Transurethral seminal vesiculoscopy is a safe, effective and feasible new method for the treatment of refractory or recrudescent hemospermia. SN - 1009-3591 UR - https://www.unboundmedicine.com/medline/citation/23862232/[Transurethral_seminal_vesiculoscopy_for_refractory_or_recurrent_hemospermia:_clinical_analysis_of_162_cases]_ L2 - https://antibodies.cancer.gov/detail/CPTC-PSAT1-1 DB - PRIME DP - Unbound Medicine ER -